NCT00040313已完成2 期
A Phase II Randomized, Controlled, Double-Masked, Dose-Finding, Multi-Center, Comparative Trial, in Parallel Groups, to Establish the Safety and Preliminary Efficacy of Intravitreal Injections of EYE001 (Anti-VEGF Pegylated Aptamer), Given Every 6 Weeks for 12 to 30 Weeks to Patients With Clinically Significant Diabetic Macular Edema (CSME) Involving the Center of the Macula
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
研究概览
简要总结
The purpose of the study is to determine whether pegaptanib sodium (Macugen) is safe and effective in slowing the leakage of fluid within the retina and thereby stabilizing or improving vision when compared to placebo injections. A total of 176 patients will be enrolled
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with clinically significant DME, VA 20/50-20/320 in the study eye and 20/100 in the fellow eye
排除标准
- 未提供
研究者
相似试验
已完成
2 期
Study Evaluating Intravitreal hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related Macular DegenerationAge-related Macular DegenerationChoroidal NeovascularizationNCT02358889Iconic Therapeutics, Inc.88
招募中
2 期
Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated CardiomyopathyNon-ischemic Dilated CardiomyopathyNCT04476901Joshua M Hare136
已完成
2 期
Non-proliferative Diabetic Retinopathy Treated With RuncaciguatDiabetic RetinopathyNCT04722991Bayer109
已完成
2 期
MK0557 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0557-027)SchizophreniaParanoid SchizophreniaNCT00482430Merck Sharp & Dohme LLC50
已完成
2 期
Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic UlcersIschemiaUlcersArterial Occlusive DiseasePeripheral Vascular DiseaseNCT00189540AnGes USA, Inc.27